France Contraceptives Drugs Market Analysis

France Contraceptives Drugs Market Analysis


$ 3999

France Contraceptives Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The contraceptive drugs market is driven by factors such as rising awareness, government initiatives, and technological advancements. Some of the global key players in this market are Pfizer Inc., Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., etc.

ID: IN10FRPH264 CATEGORY: Pharmaceuticals GEOGRAPHY: France AUTHOR: Saloni Shah

Buy Now

France Contraceptives Drugs Market Analysis Summary

France Contraceptives Drugs Market is valued at around $545.8 Mn in 2022 and is projected to reach $876.4 Mn by 2030, exhibiting a CAGR of 6.1% during the forecast period 2023-2030.

Contraceptives, also known as birth control methods or family planning methods, are techniques or devices used to prevent pregnancy. The market for contraceptive medications refers to pharmacological products intended to prevent pregnancy. It includes hormonal contraceptives (pills, patches, injections), barrier methods (condoms, diaphragms), intrauterine devices (IUDs), emergency contraception, fertility awareness methods, sterilization procedures, and various over-the-counter options. Approximately 400 million women of reproductive age use hormonal contraceptives worldwide. Rising awareness and education about family planning, government initiatives promoting reproductive health, advancements in pharmaceutical research and development, increased female workforce participation, and changing lifestyles with delayed pregnancies and smaller family sizes are driving the contraceptive drugs market. Global key players in the Contraceptives Drugs Market include Pfizer Inc., Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Novartis International AG, Gedeon Richter, Allergan plc. and Lupin Pharmaceuticals Ltd.

Market Dynamics

Market Growth Drivers

  1. Rising Awareness: As people become more aware of the necessity of family planning and contraception, the demand for contraceptive medications has increased
  2. Government Initiatives: Government programs and policies that support family planning and reproductive health help to drive market growth
  3. Advances in pharmaceutical research and development have resulted in the introduction of novel contraceptive drug formulations, such as long-acting reversible contraceptives (LARCs), which have acquired appeal among consumers
  4. Increasing Female Workforce Participation: As more women enter the labor force, there is a greater demand for effective contraceptive techniques to manage family planning and birth control
  5. Modern lives, delayed pregnancies, and a desire for smaller family numbers have all led to the rising use of contraceptive medications

Market Restraints

  1. Social Stigma and Cultural Factors: Cultural and social factors may influence contraceptive medication acceptance and use. Conservative ideas may exist in some individuals or societies, discouraging the use of contraception
  2. Side Effects and Safety Concerns: Contraceptive medicines, like any pharmaceutical product, might have potential side effects and safety concerns. These considerations may limit its acceptance, particularly among specific demographics
  3. Alternative Contraceptive Methods: Other contraceptive methods, such as barrier methods (condoms, diaphragms) and intrauterine devices, are available in the market (IUDs). Some people may prefer non-pharmaceutical alternatives, reducing the market for contraceptive medications

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • Novartis International AG
  • Gedeon Richter
  • Allergan plc.
  • Lupin Pharmaceuticals Ltd.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

France Contraceptives Drugs Market Segmentation

By Drug Type

  • Oral Contraceptives
  • Injectable Contraceptive
  • Transdermal Patches
  • Vaginal Rings
  • Emergency Contraceptives

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Clinics

By End User

  • Hospitals
  • Clinics
  • Home Care Settings

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up